GO:0005515 | protein binding | 34.87% (68/195) | 1.63 | 0.0 | 0.0 |
GO:0005488 | binding | 56.92% (111/195) | 0.85 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 17.44% (34/195) | 2.03 | 0.0 | 0.0 |
GO:0051649 | establishment of localization in cell | 7.18% (14/195) | 2.84 | 0.0 | 2e-06 |
GO:0046907 | intracellular transport | 7.18% (14/195) | 2.84 | 0.0 | 2e-06 |
GO:0051641 | cellular localization | 8.21% (16/195) | 2.54 | 0.0 | 2e-06 |
GO:0003674 | molecular_function | 70.77% (138/195) | 0.44 | 0.0 | 8e-06 |
GO:0033036 | macromolecule localization | 6.67% (13/195) | 2.7 | 0.0 | 8e-06 |
GO:0070727 | cellular macromolecule localization | 6.67% (13/195) | 2.7 | 0.0 | 8e-06 |
GO:0008104 | protein localization | 6.67% (13/195) | 2.7 | 0.0 | 8e-06 |
GO:0030117 | membrane coat | 3.59% (7/195) | 4.13 | 0.0 | 9e-06 |
GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity | 2.05% (4/195) | 6.08 | 0.0 | 1.4e-05 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 4.62% (9/195) | 3.32 | 0.0 | 1.5e-05 |
GO:0043632 | modification-dependent macromolecule catabolic process | 4.62% (9/195) | 3.32 | 0.0 | 1.5e-05 |
GO:0019941 | modification-dependent protein catabolic process | 4.62% (9/195) | 3.32 | 0.0 | 1.5e-05 |
GO:0098797 | plasma membrane protein complex | 2.56% (5/195) | 4.98 | 1e-06 | 1.9e-05 |
GO:0006886 | intracellular protein transport | 5.13% (10/195) | 3.03 | 0.0 | 2e-05 |
GO:0101005 | deubiquitinase activity | 3.59% (7/195) | 3.84 | 1e-06 | 2e-05 |
GO:0016192 | vesicle-mediated transport | 6.15% (12/195) | 2.64 | 1e-06 | 2.1e-05 |
GO:0019783 | ubiquitin-like protein peptidase activity | 3.59% (7/195) | 3.83 | 1e-06 | 2.1e-05 |
GO:0005524 | ATP binding | 17.44% (34/195) | 1.33 | 1e-06 | 2.2e-05 |
GO:0071702 | organic substance transport | 7.18% (14/195) | 2.28 | 1e-06 | 4e-05 |
GO:0015031 | protein transport | 5.64% (11/195) | 2.68 | 1e-06 | 4e-05 |
GO:0051603 | proteolysis involved in protein catabolic process | 4.62% (9/195) | 3.06 | 2e-06 | 4e-05 |
GO:0003774 | cytoskeletal motor activity | 3.59% (7/195) | 3.64 | 2e-06 | 4.2e-05 |
GO:0032559 | adenyl ribonucleotide binding | 17.44% (34/195) | 1.26 | 2e-06 | 4.4e-05 |
GO:0140513 | nuclear protein-containing complex | 5.64% (11/195) | 2.6 | 3e-06 | 5.8e-05 |
GO:0098796 | membrane protein complex | 5.64% (11/195) | 2.56 | 3e-06 | 7.4e-05 |
GO:0140658 | ATP-dependent chromatin remodeler activity | 2.56% (5/195) | 4.4 | 4e-06 | 8.1e-05 |
GO:0016459 | myosin complex | 2.05% (4/195) | 5.2 | 4e-06 | 8.2e-05 |
GO:0097367 | carbohydrate derivative binding | 18.46% (36/195) | 1.16 | 4e-06 | 8.3e-05 |
GO:0009057 | macromolecule catabolic process | 5.13% (10/195) | 2.68 | 4e-06 | 8.4e-05 |
GO:0071705 | nitrogen compound transport | 6.15% (12/195) | 2.37 | 4e-06 | 8.4e-05 |
GO:0045184 | establishment of protein localization | 5.64% (11/195) | 2.5 | 5e-06 | 8.6e-05 |
GO:0052742 | phosphatidylinositol kinase activity | 2.05% (4/195) | 5.14 | 5e-06 | 8.8e-05 |
GO:0030554 | adenyl nucleotide binding | 17.44% (34/195) | 1.17 | 6e-06 | 0.000113 |
GO:0035639 | purine ribonucleoside triphosphate binding | 17.44% (34/195) | 1.17 | 7e-06 | 0.000117 |
GO:0016070 | RNA metabolic process | 8.72% (17/195) | 1.76 | 1.3e-05 | 0.000216 |
GO:0016579 | protein deubiquitination | 2.56% (5/195) | 4.01 | 1.6e-05 | 0.00025 |
GO:0016307 | obsolete phosphatidylinositol phosphate kinase activity | 2.05% (4/195) | 4.71 | 1.6e-05 | 0.000256 |
GO:0032555 | purine ribonucleotide binding | 17.44% (34/195) | 1.11 | 1.7e-05 | 0.000263 |
GO:0017056 | structural constituent of nuclear pore | 2.05% (4/195) | 4.66 | 1.9e-05 | 0.000278 |
GO:0006650 | glycerophospholipid metabolic process | 3.59% (7/195) | 3.1 | 1.9e-05 | 0.000282 |
GO:0001727 | lipid kinase activity | 2.05% (4/195) | 4.62 | 2.1e-05 | 0.000288 |
GO:0070646 | protein modification by small protein removal | 2.56% (5/195) | 3.92 | 2.1e-05 | 0.000293 |
GO:0032553 | ribonucleotide binding | 17.44% (34/195) | 1.09 | 2.1e-05 | 0.000299 |
GO:0046486 | glycerolipid metabolic process | 3.59% (7/195) | 3.07 | 2.3e-05 | 0.000301 |
GO:0010252 | obsolete auxin homeostasis | 1.03% (2/195) | 7.66 | 2.4e-05 | 0.000311 |
GO:0030623 | U5 snRNA binding | 1.03% (2/195) | 7.66 | 2.4e-05 | 0.000311 |
GO:1901363 | heterocyclic compound binding | 18.97% (37/195) | 1.01 | 2.8e-05 | 0.000352 |
GO:0036094 | small molecule binding | 18.97% (37/195) | 1.0 | 3.4e-05 | 0.000396 |
GO:0030120 | vesicle coat | 2.05% (4/195) | 4.45 | 3.3e-05 | 0.000397 |
GO:0005643 | nuclear pore | 2.05% (4/195) | 4.45 | 3.3e-05 | 0.000397 |
GO:1903047 | mitotic cell cycle process | 2.05% (4/195) | 4.45 | 3.3e-05 | 0.000397 |
GO:0004843 | cysteine-type deubiquitinase activity | 2.56% (5/195) | 3.74 | 3.9e-05 | 0.000442 |
GO:0046488 | phosphatidylinositol metabolic process | 3.08% (6/195) | 3.26 | 4.2e-05 | 0.000473 |
GO:0017076 | purine nucleotide binding | 17.44% (34/195) | 1.03 | 5.1e-05 | 0.000566 |
GO:0043168 | anion binding | 17.95% (35/195) | 0.98 | 7.3e-05 | 0.000705 |
GO:0006611 | protein export from nucleus | 1.03% (2/195) | 7.08 | 7.3e-05 | 0.000712 |
GO:0061780 | mitotic cohesin loading | 1.03% (2/195) | 7.08 | 7.3e-05 | 0.000712 |
GO:0071921 | cohesin loading | 1.03% (2/195) | 7.08 | 7.3e-05 | 0.000712 |
GO:0017070 | U6 snRNA binding | 1.03% (2/195) | 7.08 | 7.3e-05 | 0.000712 |
GO:0071168 | protein localization to chromatin | 1.03% (2/195) | 7.08 | 7.3e-05 | 0.000712 |
GO:0034502 | protein localization to chromosome | 1.03% (2/195) | 7.08 | 7.3e-05 | 0.000712 |
GO:0110156 | methylguanosine-cap decapping | 1.54% (3/195) | 5.16 | 7.7e-05 | 0.000718 |
GO:0110154 | RNA decapping | 1.54% (3/195) | 5.16 | 7.7e-05 | 0.000718 |
GO:0019899 | enzyme binding | 2.56% (5/195) | 3.56 | 7e-05 | 0.00076 |
GO:0006644 | phospholipid metabolic process | 3.59% (7/195) | 2.71 | 0.000109 | 0.00101 |
GO:0032051 | clathrin light chain binding | 1.03% (2/195) | 6.66 | 0.000145 | 0.001227 |
GO:0006438 | valyl-tRNA aminoacylation | 1.03% (2/195) | 6.66 | 0.000145 | 0.001227 |
GO:0071439 | clathrin complex | 1.03% (2/195) | 6.66 | 0.000145 | 0.001227 |
GO:0004832 | valine-tRNA ligase activity | 1.03% (2/195) | 6.66 | 0.000145 | 0.001227 |
GO:0000166 | nucleotide binding | 17.44% (34/195) | 0.95 | 0.00014 | 0.001254 |
GO:1901265 | nucleoside phosphate binding | 17.44% (34/195) | 0.95 | 0.00014 | 0.001254 |
GO:0016887 | ATP hydrolysis activity | 4.62% (9/195) | 2.21 | 0.000163 | 0.001367 |
GO:0051020 | GTPase binding | 1.54% (3/195) | 4.79 | 0.00017 | 0.001389 |
GO:0031267 | small GTPase binding | 1.54% (3/195) | 4.79 | 0.00017 | 0.001389 |
GO:0030131 | clathrin adaptor complex | 1.54% (3/195) | 4.72 | 0.000195 | 0.001571 |
GO:0008150 | biological_process | 49.74% (97/195) | 0.42 | 0.000201 | 0.001596 |
GO:0051168 | nuclear export | 1.54% (3/195) | 4.66 | 0.000222 | 0.001744 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 1.03% (2/195) | 6.34 | 0.00024 | 0.001795 |
GO:1905393 | plant organ formation | 1.03% (2/195) | 6.34 | 0.00024 | 0.001795 |
GO:0005049 | nuclear export signal receptor activity | 1.03% (2/195) | 6.34 | 0.00024 | 0.001795 |
GO:0017069 | snRNA binding | 1.03% (2/195) | 6.34 | 0.00024 | 0.001795 |
GO:0009987 | cellular process | 34.87% (68/195) | 0.56 | 0.000271 | 0.002001 |
GO:0030119 | AP-type membrane coat adaptor complex | 1.54% (3/195) | 4.39 | 0.000394 | 0.002876 |
GO:0030276 | clathrin binding | 1.54% (3/195) | 4.34 | 0.000436 | 0.003147 |
GO:0022402 | cell cycle process | 2.56% (5/195) | 2.98 | 0.000451 | 0.003219 |
GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA | 1.03% (2/195) | 5.85 | 0.000501 | 0.003535 |
GO:0043167 | ion binding | 22.56% (44/195) | 0.71 | 0.000596 | 0.004158 |
GO:0030132 | clathrin coat of coated pit | 1.03% (2/195) | 5.66 | 0.000666 | 0.004356 |
GO:0030118 | clathrin coat | 1.03% (2/195) | 5.66 | 0.000666 | 0.004356 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 1.03% (2/195) | 5.66 | 0.000666 | 0.004356 |
GO:0030125 | clathrin vesicle coat | 1.03% (2/195) | 5.66 | 0.000666 | 0.004356 |
GO:0051179 | localization | 10.77% (21/195) | 1.13 | 0.000635 | 0.004385 |
GO:0016071 | mRNA metabolic process | 3.08% (6/195) | 2.53 | 0.000646 | 0.00441 |
GO:0044877 | protein-containing complex binding | 2.56% (5/195) | 2.84 | 0.0007 | 0.004531 |
GO:0034248 | regulation of amide metabolic process | 1.54% (3/195) | 4.0 | 0.00088 | 0.005583 |
GO:0006417 | regulation of translation | 1.54% (3/195) | 4.0 | 0.00088 | 0.005583 |
GO:0009056 | catabolic process | 5.64% (11/195) | 1.63 | 0.00095 | 0.005969 |
GO:0010608 | post-transcriptional regulation of gene expression | 1.54% (3/195) | 3.85 | 0.00118 | 0.007268 |
GO:0005575 | cellular_component | 20.0% (39/195) | 0.72 | 0.001176 | 0.007314 |
GO:0001882 | nucleoside binding | 1.03% (2/195) | 5.2 | 0.001295 | 0.007821 |
GO:0032549 | ribonucleoside binding | 1.03% (2/195) | 5.2 | 0.001295 | 0.007821 |
GO:0140142 | nucleocytoplasmic carrier activity | 1.03% (2/195) | 5.08 | 0.001549 | 0.009265 |
GO:0140657 | ATP-dependent activity | 6.15% (12/195) | 1.46 | 0.00158 | 0.009358 |
GO:0006397 | mRNA processing | 2.56% (5/195) | 2.56 | 0.001694 | 0.009944 |
GO:0043170 | macromolecule metabolic process | 22.05% (43/195) | 0.64 | 0.001801 | 0.010471 |
GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 1.54% (3/195) | 3.6 | 0.001958 | 0.01128 |
GO:0048193 | Golgi vesicle transport | 2.05% (4/195) | 2.91 | 0.002069 | 0.011813 |
GO:1901575 | organic substance catabolic process | 5.13% (10/195) | 1.58 | 0.002097 | 0.011866 |
GO:0140326 | ATPase-coupled intramembrane lipid transporter activity | 1.03% (2/195) | 4.85 | 0.002122 | 0.011899 |
GO:0051246 | regulation of protein metabolic process | 2.05% (4/195) | 2.87 | 0.002286 | 0.012705 |
GO:0006810 | transport | 9.74% (19/195) | 1.04 | 0.00238 | 0.013111 |
GO:0090304 | nucleic acid metabolic process | 9.23% (18/195) | 1.08 | 0.002415 | 0.013189 |
GO:0031124 | mRNA 3'-end processing | 1.03% (2/195) | 4.76 | 0.002441 | 0.013213 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 6.15% (12/195) | 1.38 | 0.002548 | 0.013674 |
GO:0032886 | regulation of microtubule-based process | 1.03% (2/195) | 4.57 | 0.003141 | 0.016301 |
GO:0140303 | intramembrane lipid transporter activity | 1.03% (2/195) | 4.57 | 0.003141 | 0.016301 |
GO:0051234 | establishment of localization | 9.74% (19/195) | 1.01 | 0.003125 | 0.016492 |
GO:0006351 | DNA-templated transcription | 2.56% (5/195) | 2.35 | 0.003116 | 0.016581 |
GO:0015914 | phospholipid transport | 1.03% (2/195) | 4.49 | 0.003522 | 0.017416 |
GO:0006075 | (1->3)-beta-D-glucan biosynthetic process | 1.03% (2/195) | 4.49 | 0.003522 | 0.017416 |
GO:0006074 | (1->3)-beta-D-glucan metabolic process | 1.03% (2/195) | 4.49 | 0.003522 | 0.017416 |
GO:0097346 | INO80-type complex | 1.03% (2/195) | 4.49 | 0.003522 | 0.017416 |
GO:0000148 | 1,3-beta-D-glucan synthase complex | 1.03% (2/195) | 4.49 | 0.003522 | 0.017416 |
GO:0031011 | Ino80 complex | 1.03% (2/195) | 4.49 | 0.003522 | 0.017416 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 5.13% (10/195) | 1.47 | 0.003619 | 0.017757 |
GO:0032774 | RNA biosynthetic process | 3.08% (6/195) | 2.03 | 0.003778 | 0.018394 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 5.13% (10/195) | 1.46 | 0.003868 | 0.018543 |
GO:0140535 | intracellular protein-containing complex | 3.08% (6/195) | 2.02 | 0.00384 | 0.018552 |
GO:1902494 | catalytic complex | 4.1% (8/195) | 1.67 | 0.003934 | 0.018715 |
GO:0003843 | 1,3-beta-D-glucan synthase activity | 1.03% (2/195) | 4.34 | 0.004345 | 0.020518 |
GO:1990116 | ribosome-associated ubiquitin-dependent protein catabolic process | 0.51% (1/195) | 7.66 | 0.004937 | 0.021382 |
GO:1990112 | RQC complex | 0.51% (1/195) | 7.66 | 0.004937 | 0.021382 |
GO:0004141 | dethiobiotin synthase activity | 0.51% (1/195) | 7.66 | 0.004937 | 0.021382 |
GO:0140030 | modification-dependent protein binding | 0.51% (1/195) | 7.66 | 0.004937 | 0.021382 |
GO:0070577 | lysine-acetylated histone binding | 0.51% (1/195) | 7.66 | 0.004937 | 0.021382 |
GO:0016504 | peptidase activator activity | 0.51% (1/195) | 7.66 | 0.004937 | 0.021382 |
GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity | 0.51% (1/195) | 7.66 | 0.004937 | 0.021382 |
GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 0.51% (1/195) | 7.66 | 0.004937 | 0.021382 |
GO:0140033 | acetylation-dependent protein binding | 0.51% (1/195) | 7.66 | 0.004937 | 0.021382 |
GO:0140492 | metal-dependent deubiquitinase activity | 1.03% (2/195) | 4.27 | 0.004787 | 0.022106 |
GO:0070122 | obsolete isopeptidase activity | 1.03% (2/195) | 4.27 | 0.004787 | 0.022106 |
GO:0030015 | CCR4-NOT core complex | 1.03% (2/195) | 4.27 | 0.004787 | 0.022106 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 1.54% (3/195) | 3.06 | 0.005719 | 0.024266 |
GO:0006913 | nucleocytoplasmic transport | 1.54% (3/195) | 3.06 | 0.005719 | 0.024266 |
GO:0140096 | catalytic activity, acting on a protein | 13.33% (26/195) | 0.76 | 0.00567 | 0.024388 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 4.62% (9/195) | 1.45 | 0.006067 | 0.025571 |
GO:0051169 | nuclear transport | 1.54% (3/195) | 3.02 | 0.006164 | 0.025808 |
GO:0070603 | SWI/SNF superfamily-type complex | 1.03% (2/195) | 4.08 | 0.006231 | 0.025914 |
GO:0061630 | ubiquitin protein ligase activity | 2.05% (4/195) | 2.45 | 0.006363 | 0.026291 |
GO:0061659 | ubiquitin-like protein ligase activity | 2.05% (4/195) | 2.44 | 0.006514 | 0.026738 |
GO:0005319 | lipid transporter activity | 1.03% (2/195) | 4.02 | 0.006751 | 0.027352 |
GO:1904949 | ATPase complex | 1.03% (2/195) | 4.02 | 0.006751 | 0.027352 |
GO:0003712 | transcription coregulator activity | 1.54% (3/195) | 2.96 | 0.00687 | 0.027658 |
GO:0050789 | regulation of biological process | 11.79% (23/195) | 0.79 | 0.007612 | 0.030449 |
GO:0043687 | post-translational protein modification | 3.08% (6/195) | 1.8 | 0.007899 | 0.031396 |
GO:0034249 | negative regulation of amide metabolic process | 1.03% (2/195) | 3.85 | 0.008424 | 0.032656 |
GO:0017148 | negative regulation of translation | 1.03% (2/195) | 3.85 | 0.008424 | 0.032656 |
GO:0034062 | 5'-3' RNA polymerase activity | 1.54% (3/195) | 2.85 | 0.008422 | 0.033056 |
GO:0097747 | RNA polymerase activity | 1.54% (3/195) | 2.85 | 0.008422 | 0.033056 |
GO:0097159 | organic cyclic compound binding | 26.15% (51/195) | 0.46 | 0.008814 | 0.033749 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 9.74% (19/195) | 0.86 | 0.008811 | 0.033946 |
GO:0140104 | molecular carrier activity | 1.03% (2/195) | 3.8 | 0.009019 | 0.034327 |
GO:0006396 | RNA processing | 3.59% (7/195) | 1.59 | 0.00934 | 0.035336 |
GO:0006139 | nucleobase-containing compound metabolic process | 9.74% (19/195) | 0.85 | 0.009903 | 0.035337 |
GO:1902115 | regulation of organelle assembly | 0.51% (1/195) | 6.66 | 0.00985 | 0.035346 |
GO:0070628 | proteasome binding | 0.51% (1/195) | 6.66 | 0.00985 | 0.035346 |
GO:0048017 | obsolete inositol lipid-mediated signaling | 0.51% (1/195) | 6.66 | 0.00985 | 0.035346 |
GO:0090169 | regulation of spindle assembly | 0.51% (1/195) | 6.66 | 0.00985 | 0.035346 |
GO:0046473 | phosphatidic acid metabolic process | 0.51% (1/195) | 6.66 | 0.00985 | 0.035346 |
GO:0006654 | phosphatidic acid biosynthetic process | 0.51% (1/195) | 6.66 | 0.00985 | 0.035346 |
GO:0030906 | retromer, cargo-selective complex | 0.51% (1/195) | 6.66 | 0.00985 | 0.035346 |
GO:1901673 | regulation of mitotic spindle assembly | 0.51% (1/195) | 6.66 | 0.00985 | 0.035346 |
GO:0065007 | biological regulation | 11.79% (23/195) | 0.75 | 0.010249 | 0.036362 |
GO:0016462 | pyrophosphatase activity | 4.62% (9/195) | 1.34 | 0.009747 | 0.036654 |
GO:0003777 | microtubule motor activity | 1.54% (3/195) | 2.72 | 0.010786 | 0.037842 |
GO:0007018 | microtubule-based movement | 1.54% (3/195) | 2.72 | 0.010786 | 0.037842 |
GO:0016740 | transferase activity | 16.41% (32/195) | 0.6 | 0.011089 | 0.038687 |
GO:0044255 | cellular lipid metabolic process | 3.59% (7/195) | 1.54 | 0.011185 | 0.038809 |
GO:0046483 | heterocycle metabolic process | 10.26% (20/195) | 0.8 | 0.011453 | 0.039518 |
GO:0070647 | protein modification by small protein conjugation or removal | 2.56% (5/195) | 1.9 | 0.011565 | 0.039688 |
GO:0031123 | RNA 3'-end processing | 1.03% (2/195) | 3.57 | 0.012263 | 0.041853 |
GO:0004842 | ubiquitin-protein transferase activity | 2.56% (5/195) | 1.86 | 0.01279 | 0.043417 |
GO:0015748 | organophosphate ester transport | 1.03% (2/195) | 3.53 | 0.012964 | 0.043771 |
GO:0044238 | primary metabolic process | 25.64% (50/195) | 0.43 | 0.013746 | 0.046164 |
GO:0008017 | microtubule binding | 2.05% (4/195) | 2.12 | 0.013867 | 0.046321 |
GO:0008094 | ATP-dependent activity, acting on DNA | 3.08% (6/195) | 1.61 | 0.014396 | 0.047581 |
GO:0019787 | ubiquitin-like protein transferase activity | 2.56% (5/195) | 1.81 | 0.01449 | 0.047644 |
GO:0004721 | phosphoprotein phosphatase activity | 1.54% (3/195) | 2.56 | 0.014605 | 0.047769 |
GO:0036211 | protein modification process | 9.74% (19/195) | 0.79 | 0.014395 | 0.047832 |
GO:0051377 | mannose-ethanolamine phosphotransferase activity | 0.51% (1/195) | 6.08 | 0.014738 | 0.047957 |
GO:0050794 | regulation of cellular process | 10.77% (21/195) | 0.74 | 0.014835 | 0.048024 |
GO:0016755 | aminoacyltransferase activity | 2.56% (5/195) | 1.79 | 0.015293 | 0.04925 |
GO:1901360 | organic cyclic compound metabolic process | 10.26% (20/195) | 0.76 | 0.015373 | 0.049258 |